United States
Valeant to drop deal-making in near term to cut debt, boost stock
Valeant Pharmaceuticals International Inc (VRX.TO) is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position, people familiar with the matter told Reuters.
Merck to take on superbugs with Cubist Pharma buy
Merck & Co Inc (MRK.N) said it would buy Cubist Pharmaceuticals Inc (CBST.O) for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that combat so-called superbugs.
U.S. shale output still surges, to add 103,000 bpd by Jan-EIA
Oil production from the United States' biggest shale plays is poised to keep expanding at the same breakneck pace into early next year, according to new U.S. projections released on Monday that highlighted a slow response to tumbling prices.
Portland, Oregon, sues to stop Uber online car service
Portland sued Uber on Monday to stop the fast-growing ride-hailing service from operating in the Oregon city until it follows local regulations.




